Overview
Stephanie Kaiser is a Nurse Practitioner in Pittsburgh, Pennsylvania. Ms. Kaiser is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
Excela Health Physician Practices, Inc
Danielle Smith is a Nurse Practitioner in Greensburg, Pennsylvania. Ms. Smith is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, and Non-Alcoholic Fatty Liver Disease.
West Virginia University Medical Corporation
Adrienne Duckworth is a Nurse Practitioner in Morgantown, West Virginia. Ms. Duckworth is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer. Ms. Duckworth is currently accepting new patients.
Wheeling Hospital Inc
Bobbie Saleh is a Nurse Practitioner in Wheeling, West Virginia. Ms. Saleh is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma, Small Lymphocytic Lymphoma (SLL), and Gastroesophageal Junction Cancer. Ms. Saleh is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Kaiser isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.